Previous 10 | Next 10 |
Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...
Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...
Chembio Diagnostics Inc. (NASDAQ:CEMI) traded today at a new 52-week low of $2.40. This new low was reached on below average trading volume as 115,000 shares traded hands, while the average 30-day volume is approximately 531,000 shares. Chembio Diagnostics Inc is a company that develops,...
Shares of Chembio Diagnostics Inc. (NASDAQ:CEMI) traded today at $2.66, breaking its 52-week low. So far today approximately 115,000 shares have been exchanged, as compared to an average 30-day volume of 533,000 shares. Potential upside of 20.9% exists for Chembio Diagnostics Inc., based...
Chembio Diagnostics Inc. (NASDAQ:CEMI) traded at a new 52-week low today of $2.83. So far today approximately 115,000 shares have been exchanged, as compared to an average 30-day volume of 448,000 shares. Chembio Diagnostics Inc is a company that develops, manufactures, and commercialize...
Shares of Chembio Diagnostics Inc. (NASDAQ:CEMI) traded today at $2.81, breaking its 52-week low. This new low was reached on below average trading volume as 115,000 shares traded hands, while the average 30-day volume is approximately 448,000 shares. Chembio Diagnostics Inc is a company...
Shares of Chembio Diagnostics Inc. (NASDAQ:CEMI) traded at a new 52-week low today of $2.83. So far today approximately 115,000 shares have been exchanged, as compared to an average 30-day volume of 448,000 shares. Over the past year, Chembio Diagnostics Inc. has traded in a range of $2....
Chembio Diagnostics (CEMI): Q1 GAAP EPS of -$0.22 beats by $0.10.Revenue of $8.72M (+27.1% Y/Y) beats by $0.53M.Press Release For further details see: Chembio Diagnostics EPS beats by $0.10, beats on revenue
HAUPPAUGE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2021. Chembio achieved first quarter 2021 total revenue of...
(Polina Tankilevitch/Pexels) (The Street) — Precipio (NASDAQ:PRPO) skyrocketed Monday after the specialty diagnostics company said it had launched its COVID-19 ...
News, Short Squeeze, Breakout and More Instantly...
Chembio Diagnostics Inc. Company Name:
CEMI Stock Symbol:
NASDAQ Market:
Chembio Diagnostics Inc. Website:
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 ...